IRF7: Activation, Regulation, Modification and Function

Overview

Journal Genes Immun

Date 2011 Apr 15

PMID 21490621

Citations 295

Authors

S Ning

J S Pagano

G N Barber

Affiliations

Soon will be listed here.

Abstract

Interferon regulatory factor 7 (IRF7) was originally identified in the context of Epstein-Barr virus (EBV) infection, and has since emerged as the crucial regulator of type I interferons (IFNs) against pathogenic infections, which activate IRF7 by triggering signaling cascades from pathogen recognition receptors (PRRs) that recognize pathogenic nucleic acids. Moreover, IRF7 is a multifunctional transcription factor, underscored by the fact that it is associated with EBV latency, in which IRF7 is induced as well as activated by the EBV principal oncoprotein latent membrane protein-1 (LMP1). Aberrant production of type I IFNs is associated with many types of diseases such as cancers and autoimmune disorders. Thus, tight regulation of IRF7 expression and activity is imperative in dictating appropriate type I IFN production for normal IFN-mediated physiological functions. Posttranslational modifications have important roles in regulation of IRF7 activity, exemplified by phosphorylation, which is indicative of its activation. Furthermore, mounting evidence has shed light on the importance of regulatory ubiquitination in activation of IRF7. Albeit these exciting findings have been made in the past decade since its discovery, many questions related to IRF7 remain to be addressed.

Citing Articles

RGS2 is an innate immune checkpoint for suppressing Gαq-mediated IFNγ generation and lung injury.

Joshi J, Joshi B, Zhang C, Banerjee S, Vellingiri V, Raghunathrao V iScience. 2025; 28(2):111878.

PMID: 40041768 PMC: 11876898. DOI: 10.1016/j.isci.2025.111878.

Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing.

Xu Y, Bai X, Lin J, Lu K, Weng S, Wu Y Mol Ther Methods Clin Dev. 2025; 33(1):101420.

PMID: 40034424 PMC: 11874542. DOI: 10.1016/j.omtm.2025.101420.

Long noncoding RNA PARAL1 regulates myeloid dendritic cell differentiation and TLR signaling.

Naqvi R, Valverde A, Shukla D, Naqvi A Genes Immun. 2025; .

PMID: 40000873 DOI: 10.1038/s41435-025-00323-9.

Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury.

Long Q, Rabi K, Cai Y, Li L, Huang S, Qian B Nat Commun. 2025; 16(1):1909.

PMID: 39994192 PMC: 11850716. DOI: 10.1038/s41467-025-57048-6.

Cytoplasmic Shift of Interferon Regulatory Factors Co-Evolved With Jawed Vertebrate Innate Immunity.

Hubing V, Marquis A, Ziemann C, Moriyama H, Moriyama E, Zhang L J Med Virol. 2025; 97(2):e70247.

PMID: 39977406 PMC: 11841930. DOI: 10.1002/jmv.70247.

References

Romieu-Mourez R, Solis M, Nardin A, Goubau D, Baron-Bodo V, Lin R . Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res. 2006; 66(21):10576-85. DOI: 10.1158/0008-5472.CAN-06-1279. View

Eliopoulos A, Young L . LMP1 structure and signal transduction. Semin Cancer Biol. 2001; 11(6):435-44. DOI: 10.1006/scbi.2001.0410. View

Honda K, Taniguchi T . IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006; 6(9):644-58. DOI: 10.1038/nri1900. View

Chen Z, Sun L . Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell. 2009; 33(3):275-86. DOI: 10.1016/j.molcel.2009.01.014. View

tenOever B, Sharma S, Zou W, Sun Q, Grandvaux N, Julkunen I . Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J Virol. 2004; 78(19):10636-49. PMC: 516426. DOI: 10.1128/JVI.78.19.10636-10649.2004. View

Welchman R, Gordon C, Mayer R . Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol. 2005; 6(8):599-609. DOI: 10.1038/nrm1700. View

Sun W, Li Y, Chen L, Chen H, You F, Zhou X . ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci U S A. 2009; 106(21):8653-8. PMC: 2689030. DOI: 10.1073/pnas.0900850106. View

Fukasawa M, Kimura M, Morita S, Matsubara K, Yamanaka S, Endo C . Microarray analysis of promoter methylation in lung cancers. J Hum Genet. 2006; 51(4):368-374. DOI: 10.1007/s10038-005-0355-4. View

Sadler A, Williams B . Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008; 8(7):559-68. PMC: 2522268. DOI: 10.1038/nri2314. View

10.

Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseno C, Gires O . Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene. 2005; 24(10):1711-7. DOI: 10.1038/sj.onc.1208367. View

11.

Genin P, Lin R, Hiscott J, Civas A . Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7. Mol Cell Biol. 2009; 29(12):3435-50. PMC: 2698742. DOI: 10.1128/MCB.01805-08. View

12.

Daubeuf S, Singh D, Tan Y, Liu H, Federoff H, Bowers W . HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood. 2008; 113(14):3264-75. PMC: 3401030. DOI: 10.1182/blood-2008-07-168203. View

13.

Colina R, Costa-Mattioli M, Dowling R, Jaramillo M, Tai L, Breitbach C . Translational control of the innate immune response through IRF-7. Nature. 2008; 452(7185):323-8. DOI: 10.1038/nature06730. View

14.

Fujii Y, Shimizu T, Kusumoto M, Kyogoku Y, Taniguchi T, Hakoshima T . Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J. 1999; 18(18):5028-41. PMC: 1171574. DOI: 10.1093/emboj/18.18.5028. View

15.

Xiao C, Rajewsky K . MicroRNA control in the immune system: basic principles. Cell. 2009; 136(1):26-36. DOI: 10.1016/j.cell.2008.12.027. View

16.

Okabe Y, Kawane K, Nagata S . IFN regulatory factor (IRF) 3/7-dependent and -independent gene induction by mammalian DNA that escapes degradation. Eur J Immunol. 2008; 38(11):3150-8. DOI: 10.1002/eji.200838559. View

17.

Meulmeester E, Melchior F . Cell biology: SUMO. Nature. 2008; 452(7188):709-11. DOI: 10.1038/452709a. View

18.

Chattopadhyay S, Marques J, Yamashita M, Peters K, Smith K, Desai A . Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J. 2010; 29(10):1762-73. PMC: 2876960. DOI: 10.1038/emboj.2010.50. View

19.

Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, Takaoka A . Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun. 2003; 306(4):860-6. DOI: 10.1016/s0006-291x(03)01049-0. View

20.

Tang X, Gao J, Guan Y, McLane K, Yuan Z, Ramratnam B . Acetylation-dependent signal transduction for type I interferon receptor. Cell. 2007; 131(1):93-105. DOI: 10.1016/j.cell.2007.07.034. View